Norges Bank’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-751,604
| Closed | -$44.2M | – | 1993 |
|
|
2023
Q4 | $44.2M | Buy |
751,604
+319,661
| +74% | +$18.8M | 0.01% | 958 |
|
|
2023
Q3 | $18.8M | Hold |
431,943
| – | – | ﹤0.01% | 1256 |
|
|
2023
Q2 | $15.6M | Sell |
431,943
-225,295
| -34% | -$8.14M | ﹤0.01% | 1364 |
|
|
2023
Q1 | $24.4M | Buy |
657,238
+181,246
| +38% | +$6.74M | 0.01% | 1195 |
|
|
2022
Q4 | $21.6M | Buy |
475,992
+38,362
| +9% | +$1.74M | 0.01% | 1225 |
|
|
2022
Q3 | $30.6M | Buy |
437,630
+23,641
| +6% | +$1.65M | 0.01% | 997 |
|
|
2022
Q2 | $27.8M | Buy |
413,989
+18,265
| +5% | +$1.23M | 0.01% | 1078 |
|
|
2022
Q1 | $32.5M | Hold |
395,724
| – | – | 0.01% | 1122 |
|
|
2021
Q4 | $58M | Buy |
395,724
+40,077
| +11% | +$5.88M | 0.01% | 866 |
|
|
2021
Q3 | $62.9M | Sell |
355,647
-12,315
| -3% | -$2.18M | 0.01% | 807 |
|
|
2021
Q2 | $59.4M | Sell |
367,962
-22,094
| -6% | -$3.57M | 0.01% | 872 |
|
|
2021
Q1 | $66.8M | Sell |
390,056
-56,434
| -13% | -$9.67M | 0.02% | 812 |
|
|
2020
Q4 | $98.1M | Sell |
446,490
-14,070
| -3% | -$3.09M | 0.02% | 598 |
|
|
2020
Q3 | $76.5M | Buy |
460,560
+12,535
| +3% | +$2.08M | 0.02% | 646 |
|
|
2020
Q2 | $51.2M | Buy |
448,025
+58,575
| +15% | +$6.69M | 0.01% | 819 |
|
|
2020
Q1 | $29.9M | Buy |
389,450
+38,234
| +11% | +$2.94M | 0.01% | 979 |
|
|
2019
Q4 | $45.3M | Buy |
351,216
+128,080
| +57% | +$16.5M | 0.01% | 987 |
|
|
2019
Q3 | $17.4M | Buy |
+223,136
| New | +$17.4M | 0.01% | 1548 |
|